Cargando…

Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19

BACKGROUND: Soluble suppressor of tumorigenicity-2 (sST2) is a biomarker for heart failure and pulmonary injury. We hypothesize that sST2 could help predict severity of SARS-CoV-2 infections. METHODS: sST2 was analyzed in patients consecutively admitted for SARS-CoV-2 pneumonia. Other prognostic mar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arnaldos-Carrillo, María, Noguera-Velasco, José Antonio, Martínez-Ardil, Isabel M., Riquelme-Pérez, Alejandro, Cebreiros-López, Iria, Hernández-Vicente, Álvaro, Ros-Lucas, José Antonio, Khan, Amjad, Bayes-Genís, Antoni, Pascual-Figal, Domingo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier España, S.L.U. 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10086099/ https://www.ncbi.nlm.nih.gov/pubmed/37137804 http://dx.doi.org/10.1016/j.medcli.2023.04.005

Ejemplares similares

CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia
por: Ros-Lucas, José Antonio, et al.
Publicado: (2022)

Colchicine in Recently Hospitalized Patients with COVID-19: A Randomized Controlled Trial (COL-COVID)
por: Pascual-Figal, Domingo A, et al.
Publicado: (2021)

Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat
por: González-Juanatey, José Ramón, et al.
Publicado: (2023)

Compelling Benefit of Soluble Suppression of Tumorigenicity‐2 in Post–Myocardial Infarction Estimation of Risk: The Time Is Right for Its Routine Use in the Clinic
por: Díez, Javier, et al.
Publicado: (2017)

The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI
por: Asensio-Lopez, Maria Carmen, et al.
Publicado: (2021)

Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis
por: Lax, Antonio, et al.
Publicado: (2023)

Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
por: del Carmen Asensio Lopez, Maria, et al.
Publicado: (2020)

In Vitro Hemocompatibility and Genotoxicity Evaluation of Dual-Labeled [(99m)Tc]Tc-FITC-Silk Fibroin Nanoparticles for Biomedical Applications
por: Asensio Ruiz, María Alejandra, et al.
Publicado: (2023)

Decoding empagliflozin’s molecular mechanism of action in heart failure with preserved ejection fraction using artificial intelligence
por: Bayes-Genis, Antoni, et al.
Publicado: (2021)

Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
por: Asensio Lopez, Maria del Carmen, et al.
Publicado: (2020)

Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
por: Pascual-Figal, Domingo, et al.
Publicado: (2021)

Unraveling the Molecular Mechanism of Action of Empagliflozin in Heart Failure With Reduced Ejection Fraction With or Without Diabetes
por: Iborra-Egea, Oriol, et al.
Publicado: (2019)

A meta-analysis of soluble suppression of tumorigenicity 2 (sST2) and clinical outcomes in pulmonary hypertension
por: Luk, King Sum, et al.
Publicado: (2017)

Reference interval and the role of soluble suppression of tumorigenicity 2 (sST2) in subclinical cardiac dysfunction at health checkups
por: Nah, Eun‐Hee, et al.
Publicado: (2020)

Neprilysin inhibition, endorphin dynamics, and early symptomatic improvement in heart failure: a pilot study
por: Revuelta‐López, Elena, et al.
Publicado: (2020)

Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020)

The DELIVER Trial: the Beginning of the End of Ejection Fraction Tyranny
por: Bayes-Genis, Antoni
Publicado: (2022)

Differential and Predictive Value of Galectin-3 and Soluble Suppression of Tumorigenicity-2 (sST2) in Heart Failure with Preserved Ejection Fraction
por: Cui, Yameng, et al.
Publicado: (2018)

Identifying very low-risk STEMI patients for early ICU discharge in the COVID-19 era
por: Altisent, Omar Abdul-Jawad, et al.
Publicado: (2020)

The Challenging and Amazing Field of Sports Cardiology
por: Adamuz, M. Carmen, et al.
Publicado: (2020)

Radiological protection in SST aircraft
por: Fuller, E W, et al.
Publicado: (1971)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Role of SST, CORT and ghrelin and its receptors at the endocrine pancreas
por: Beléen, Chanclón, et al.
Publicado: (2012)

Impact of a ‘stent for life’ initiative on post‐ST elevation myocardial infarction heart failure: a 15 year heart failure clinic experience
por: Bayes‐Genis, Antoni, et al.
Publicado: (2017)

Translational proteomics in cardiogenic shock: from benchmark to bedside
por: Iborra-Egea, Oriol, et al.
Publicado: (2022)

Soluble suppression of tumorigenicity 2 (sST2) for predicting disease severity or mortality outcomes in cardiovascular diseases: A systematic review and meta-analysis
por: Ip, Christina, et al.
Publicado: (2021)

Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)
por: Chen, Dongqing, et al.
Publicado: (2023)

Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension
por: Codina, Pau, et al.
Publicado: (2022)

Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes
por: Asensio-López, Mari C., et al.
Publicado: (2017)

The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer
por: Puig-Domingo, Manel, et al.
Publicado: (2014)

Can Natriuretic Peptides be Used to Guide Therapy?
por: Bayes-Genis, Antoni, et al.
Publicado: (2016)

Pannenserie l sst Kosten explodieren
Publicado: (2009)

Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial
por: Khan, Amjad, et al.
Publicado: (2022)

Tumor Suppressor WWOX Contributes to the Elimination of Tumorigenic Cells in Drosophila melanogaster
por: O’Keefe, Louise V., et al.
Publicado: (2015)

Surface ECG interatrial block-guided treatment for stroke prevention: rationale for an attractive hypothesis
por: Bayés de Luna, Antoni, et al.
Publicado: (2017)

Resultados de una consulta telefónica entre cardiología y atención primaria previa a la derivación de casos dudosos a urgencias hospitalarias
por: Manzano Fernández, Sergio, et al.
Publicado: (2022)

Are mesenchymal stem cells and derived extracellular vesicles valuable to halt the COVID-19 inflammatory cascade? Current evidence and future perspectives
por: Monguió-Tortajada, Marta, et al.
Publicado: (2021)

Atrial Mitral and Tricuspid Regurgitation: Sex Matters. A Call for Action to Unravel the Differences Between Women and Men
por: Gual-Capllonch, Francisco, et al.
Publicado: (2022)

Neuroendocrine Carcinoma of the Uterine Cervix: A Clinicopathologic and Immunohistochemical Study with Focus on Novel Markers (Sst2–Sst5)
por: Inzani, Frediano, et al.
Publicado: (2020)

Bioluminescence imaging: a shining future for cardiac regeneration
por: Roura, Santiago, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n6lmiudc1vh03hn2d73rv8gbcv